Rhythm Pharmaceuticals, Inc.
RYTM
$103.94
$2.552.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.76% | 48.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.76% | 48.31% | |||
| Cost of Revenue | -0.79% | 51.95% | |||
| Gross Profit | 6.61% | 47.85% | |||
| SG&A Expenses | 14.10% | 17.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.82% | 17.68% | |||
| Operating Income | -16.24% | 3.63% | |||
| Income Before Tax | -14.04% | 6.32% | |||
| Income Tax Expenses | -67.06% | 321.25% | |||
| Earnings from Continuing Operations | -13.45% | 5.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.45% | 5.79% | |||
| EBIT | -16.24% | 3.63% | |||
| EBITDA | -16.55% | 3.66% | |||
| EPS Basic | -8.73% | 6.51% | |||
| Normalized Basic EPS | -9.62% | 7.25% | |||
| EPS Diluted | -8.73% | 6.51% | |||
| Normalized Diluted EPS | -9.62% | 7.25% | |||
| Average Basic Shares Outstanding | 4.05% | 0.99% | |||
| Average Diluted Shares Outstanding | 4.05% | 0.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||